Literature DB >> 17429098

Fatal reactivation of hepatitis B with temozolomide.

Jai Grewal, Caryl A Dellinger, W K A Yung.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17429098     DOI： 10.1056/NEJMc063696

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  20 in total

1.  Temozolomide-induced liver damage. A case report.

Authors:  F Becker; M Hecht; J Schmidtner; S Semrau; R Fietkau
Journal:  Strahlenther Onkol       Date:  2014-01-24       Impact factor: 3.621

Review 2.  Hepatitis B virus management to prevent reactivation after chemotherapy: a review.

Authors:  Jessica P Hwang; John M Vierling; Andrew D Zelenetz; Susan C Lackey; Rohit Loomba
Journal:  Support Care Cancer       Date:  2012-08-30       Impact factor: 3.603

3.  Valproic acid sensitizes human glioma cells for temozolomide and γ-radiation.

Authors:  Krista A Van Nifterik; Jaap Van den Berg; Ben J Slotman; M Vincent M Lafleur; Peter Sminia; Lukas J A Stalpers
Journal:  J Neurooncol       Date:  2011-10-26       Impact factor: 4.130

Review 4.  Severe sustained cholestatic hepatitis following temozolomide in a patient with glioblastoma multiforme: case study and review of data from the FDA adverse event reporting system.

Authors:  Giselle Sarganas; Hans D Orzechowski; Andreas Klimpel; Michael Thomae; Wolfgang Kauffmann; Hermann Herbst; Elisabeth Bronder; Edeltraut Garbe
Journal:  Neuro Oncol       Date:  2012-03-06       Impact factor: 12.300

5.  Hepatitis B virus reactivation associated with temozolomide for malignant glioma: a case report and recommendation for prophylaxis.

Authors:  Yasunori Fujimoto; Naoya Hashimoto; Manabu Kinoshita; Yuko Miyazaki; Satoshi Tanaka; Takayuki Yakushijin; Tetsuo Takehara; Naoki Kagawa; Toshiki Yoshimine
Journal:  Int J Clin Oncol       Date:  2011-08-03       Impact factor: 3.402

Review 6.  Medical management of brain tumors and the sequelae of treatment.

Authors:  David Schiff; Eudocia Q Lee; Lakshmi Nayak; Andrew D Norden; David A Reardon; Patrick Y Wen
Journal:  Neuro Oncol       Date:  2014-10-30       Impact factor: 12.300

Review 7.  Occult hepatitis B virus and hepatocellular carcinoma.

Authors:  Teresa Pollicino; Carlo Saitta
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

8.  Hepatitis B virus reactivation during temozolomide administration for malignant glioma.

Authors:  Takuhiro Shoji; Masayuki Kanamori; Jun Inoue; Ryuta Saito; Yoshinari Osada; Yoshiteru Shimoda; Masashi Chonan; Hiroshi Uenohara; Atsushi Masamune; Teiji Tominaga
Journal:  Int J Clin Oncol       Date:  2020-10-28       Impact factor: 3.402

Review 9.  Occult HBV infection.

Authors:  Giovanni Raimondo; Gaia Caccamo; Roberto Filomia; Teresa Pollicino
Journal:  Semin Immunopathol       Date:  2012-07-26       Impact factor: 9.623

10.  Toxicity after radiochemotherapy for glioblastoma using temozolomide--a retrospective evaluation.

Authors:  Marcus Niewald; Christian Berdel; Jochen Fleckenstein; Norbert Licht; Ralf Ketter; Christian Rübe
Journal:  Radiat Oncol       Date:  2011-10-21       Impact factor: 3.481
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.